The Role of Protease-Activated Receptor 2 in Hepatocellular Carcinoma after Hepatectomy

Background and Objectives: Protease activated receptor-2 (PAR2) is elevated in a variety of cancers and has been promoted as a potential therapeutic target. However, the clinical and prognostic values of PAR2 in hepatocellular carcinoma (HCC) are poorly characterized. This study aimed to evaluate th...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Medicina (Kaunas)
Prif Awduron: Tsai, Ming-Chao, Lin, Chih-Che, Chen, Ding-Wei, Liu, Yueh-Wei, Wu, Yi-Ju, Yen, Yi-Hao, Huang, Pao-Yuan, Yao, Chih-Chien, Chuang, Ching-Hui, Hsiao, Chang-Chun
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: MDPI 2021
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC8229727/
https://ncbi.nlm.nih.gov/pubmed/34199695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/medicina57060574
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg